Skip to Content
77 Mass Ave

Outwitting cancer

A drug combination makes chemo more effective.
August 21, 2019
Skin cancer cells--squamous cell carcinoma
Skin cancer cells--squamous cell carcinomaMarkus Schober and Elaine Fuchs, The Rockefeller University; NIH Image Gallery | FLickr

Many chemotherapy drugs kill cancer cells by severely damaging their DNA. However, a DNA repair pathway allows some tumors to survive and introduces mutations that help cells resist future treatment.

Researchers at MIT and Duke have discovered a drug compound that can block this repair pathway. When they treated mice with this compound along with cisplatin, a DNA-damaging drug used as the first treatment option for at least a dozen types of cancer, tumors shrank much more than those treated with cisplatin alone.

An important mechanism cancer cells use to outwit chemo relies on enzymes called translesion synthesis (TLS) polymerases to essentially copy over damaged DNA. The copying is not very accurate, but the resulting mutations are themselves an obstacle to successful chemotherapy.

The Duke collaborators screened about 10,000 potential drug compounds and identified one that binds tightly to one of the TLS polymerase components, preventing a functional polymerase from forming. When the MIT team tested this compound with cisplatin in several types of human cancer cells and in a mouse model of cancer, the combination killed many more cells than cisplatin alone. Moreover, the cells that survived were much less likely to generate new mutations.

The research team includes Nimrat Chatterjee, an MIT postdoc and a lead author of the study, and biology professors Graham Walker and Michael Hemann.

Keep Reading

Most Popular

This startup wants to copy you into an embryo for organ harvesting

With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.

VR is as good as psychedelics at helping people reach transcendence

On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.

This nanoparticle could be the key to a universal covid vaccine

Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.